Home » Topics » BioWorld Science

BioWorld Science
RSS

Dr. Reddy's licenses anti-BCMA CAR T PRG-1801 for India

May 14, 2021

Dosing begins in phase II trial of CGB-400 for rosacea

May 14, 2021

Engineering blood cells can treat brain diseases

May 13, 2021

AzurRx reports phase II interim data on MS-1819 for severe exocrine pancreatic insufficiency

May 13, 2021

Xilio presents preclinical data on tumor-selective anti-CTLA-4 antibody XTX-101

May 13, 2021

Dosing begins in phase II trial of onapristone and anastrozole in endometrial cancer

May 13, 2021

OCS-02 shows safety and efficacy in phase II study in patients with acute anterior uveitis

May 13, 2021

HU-6 enters phase II development as potential treatment of NASH

May 13, 2021

Clene Nanomedicine presents preliminary phase II data for CNM-Au8 in ALS

May 13, 2021

Preclinical characterization of novel 3CL(pro) inhibitors against COVID-19

May 13, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...